tradingkey.logo

Biodexa Pharmaceuticals PLC

BDRX
View Detailed Chart

7.040USD

+0.130+1.88%
Close 08/14, 16:00ETQuotes delayed by 15 min
47.07BMarket Cap
--P/E TTM

Biodexa Pharmaceuticals PLC

7.040

+0.130+1.88%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.88%

5 Days

+3.53%

1 Month

+618.37%

6 Months

+64.87%

Year to Date

+73.83%

1 Year

-51.46%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
STRONG BUY
Current Rating
180.000
Target Price
2504.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Biodexa Pharmaceuticals PLC
BDRX
1
CRISPR Therapeutics AG
CRSP
29
Ionis Pharmaceuticals Inc
IONS
27
Intellia Therapeutics Inc
NTLA
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(0)
Neutral(2)
Buy(10)
Indicators
Sell(0)
Neutral(2)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.423
Buy
RSI(14)
78.755
Buy
STOCH(KDJ)(9,3,3)
58.681
Neutral
ATR(14)
0.990
High Vlolatility
CCI(14)
41.471
Neutral
Williams %R
21.646
Buy
TRIX(12,20)
10.531
Buy
StochRSI(14)
13.725
Oversold
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
6.993
Buy
MA10
6.918
Buy
MA20
4.244
Buy
MA50
2.272
Buy
MA100
1.831
Buy
MA200
3.049
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.
Ticker SymbolBDRX
CompanyBiodexa Pharmaceuticals PLC
CEOMr. Stephen A. Stamp
Websitehttps://www.biodexapharma.com/
KeyAI